• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immunohorizons . Highly pathogenic avian influenza: a One Health perspective on risks, surveillance, and resilience

tetano

Editor, Senior Moderator
Immunohorizons


. 2025 Dec 5;9(SI):vlaf061.
doi: 10.1093/immhor/vlaf061. Highly pathogenic avian influenza: a One Health perspective on risks, surveillance, and resilience

Timothy N Chou[SUP] 1 [/SUP], Elena N Naumova[SUP] 1 2 [/SUP], Jonathon D Gass Jr[SUP] 1 3 [/SUP]



Affiliations
Abstract

Highly pathogenic avian influenza (HPAI) poses an expanding global threat with direct relevance to immunologists studying host-pathogen dynamics, cross-species transmission, and immune responses to emerging viruses. Driven primarily by evolving H5 and H7 influenza A subtypes, HPAI now affects a broadening host range, including spillovers into mammals such as seals, cattle, and humans, raising concern for pandemic potential. Applying a One Health perspective, this review emphasizes the immunological and ecological factors that underlie HPAI emergence and spread. Migratory bird flyways, shared aquatic habitats, and intensive poultry systems create viral mixing zones that promote antigenic diversification and interspecies transmission. Climate change and land-use transformation exacerbate these risks by altering host distributions and increasing interfaces between wildlife, livestock, and people. While poultry vaccines are widely used, human vaccine development faces challenges from antigenic drift, clade variation, and limited cross-protective immunity. Immunologists play a critical role in understanding these dynamics, particularly regarding host immune barriers, viral adaptation, and the development of broad-spectrum or next-generation vaccines. Technological advances in pathogen surveillance, such as AI-driven forecasting, genomic sequencing, and real-time risk mapping, are promising early-warning tools, but require stronger integration across human, animal, and environmental health sectors. Addressing HPAI's complex immunoecological dynamics demands a One Health approach: cross-sectoral data sharing, coordinated response strategies, and investment in resilient health systems. As HPAI continues to evolve and expand its host range, sustained global investment in One Health governance, research, and infrastructure will be vital to prevent future pandemics and safeguard health across species.

Keywords: One Health; environment; highly pathogenic avian influenza; surveillance; transmission.

 
Back
Top Bottom